10/14/2020

First implant of CEB-01 in an adult patient with sarcoma

Dr. Lucas Krauel and Dr. JA González at the Hospital de la Santa Creu i Sant Pau de Barcelona.

Promising results after the implant of CEB-01, currently in Clinical Phase

In August 2020, CEB-01 was implanted in a first patient with retroperitoneal soft tissue sarcoma at the Hospital de la Santa Creu i Sant Pau (Barcelona) under the clinical study led by Dr. Pousa.

Eight weeks after the procedure, no adverse events have been detected, nor post-surgical complications and/or toxicity linked to the product developed by Cebiotex.

There are currently two precandidates under evaluation for their inclusion in the study CEB-01-RLS01-CT.

You might also be interested in

CEBIOTEX receives approval to initiate a paediatric phase II clinical trial for locally resectable abdominal tumours

We are excited to share that the clinical trial to

Expansión: “Cebiotex abre una ronda de 1,6 millones e inicia un ensayo” (Spanish)